Crosstalk between dysfunctional mitochondria and inflammation in glaucomatous neurodegeneration

AH Jassim, DM Inman, CH Mitchell - Frontiers in pharmacology, 2021 - frontiersin.org
Mitochondrial dysfunction and excessive inflammatory responses are both sufficient to
induce pathology in age-dependent neurodegenerations. However, emerging evidence …

Inducible rodent models of glaucoma

IH Pang, AF Clark - Progress in retinal and eye research, 2020 - Elsevier
Glaucoma is one of the leading causes of vision impairment worldwide. In order to further
understand the molecular pathobiology of this disease and to develop better therapies …

Interplay between Müller cells and microglia aggravates retinal inflammatory response in experimental glaucoma

X Hu, GL Zhao, MX Xu, H Zhou, F Li, Y Miao… - Journal of …, 2021 - Springer
Background Glaucoma, the leading cause of irreversible blindness, is a retinal
neurodegenerative disease, which results from progressive apoptotic death of retinal …

Inhibition of the classical pathway of the complement cascade prevents early dendritic and synaptic degeneration in glaucoma

PA Williams, JR Tribble, KW Pepper, SD Cross… - Molecular …, 2016 - Springer
Background Glaucoma is a complex, multifactorial disease characterised by the loss of
retinal ganglion cells and their axons leading to a decrease in visual function. The earliest …

[HTML][HTML] VEGF-A is necessary and sufficient for retinal neuroprotection in models of experimental glaucoma

RH Foxton, A Finkelstein, S Vijay… - The American journal of …, 2013 - Elsevier
Vascular endothelial growth factor A (VEGF-A) is a validated therapeutic target in several
angiogenic-and vascular permeability–related pathological conditions, including certain …

[HTML][HTML] Understanding glaucomatous damage: anatomical and functional data from ocular hypertensive rodent retinas

M Vidal-Sanz, M Salinas-Navarro… - Progress in retinal and …, 2012 - Elsevier
Glaucoma, the second most common cause of blindness, is characterized by a progressive
loss of retinal ganglion cells and their axons, with a concomitant loss of the visual field …

Therapeutic drugs and devices for tackling ocular hypertension and glaucoma, and need for neuroprotection and cytoprotective therapies

NA Sharif - Frontiers in pharmacology, 2021 - frontiersin.org
Damage to the optic nerve and the death of associated retinal ganglion cells (RGCs) by
elevated intraocular pressure (IOP), also known as glaucoma, is responsible for visual …

Neuroprotection in glaucoma: animal models and clinical trials

M Almasieh, LA Levin - Annual review of vision science, 2017 - annualreviews.org
Glaucoma is a progressive neurodegenerative disease that frequently results in irreversible
blindness. Glaucoma causes death of retinal ganglion cells (RGCs) and their axons in the …

Structural basis of glaucoma: the fortified astrocytes of the optic nerve head are the target of raised intraocular pressure

C Dai, PT Khaw, ZQ Yin, D Li, G Raisman, Y Li - Glia, 2012 - Wiley Online Library
Increased intraocular pressure (IOP) damages the retinal ganglion cell axons as they pass
through the optic nerve head (ONH). The massive connective tissue structure of the human …

Review of rodent hypertensive glaucoma models

S Biswas, KH Wan - Acta ophthalmologica, 2019 - Wiley Online Library
Glaucoma is a neurodegenerative disease characterized by the progressive loss of retinal
ganglion cells (RGC s). Elevated intraocular pressure (IOP) is a primary risk factor for the …